Executive Overview · English
Shareable summary for an initial professional, technical or strategic assessment.
The public website explains architecture, evidence, limitations and development status. The Executive Overview consolidates those elements into a document that can be shared internally. Deeper technical or confidential material is not published indiscriminately; access is staged according to the purpose and depth of the review.
The public summary brings together six elements: the architecture, Version 1 evidence, APS, the Version 2 validation path, the planned later live-validation stage and documentation principles. It is available in English and German and is written for a professional reader without requiring knowledge of internal project terminology.
The Executive Overview summarises the documented Version 1 research state, the APS Risk Layer, the Version 2 validation path, the planned later live-validation stage and the principles of traceable documentation. It is deliberately public: enough substance for an initial domain, technology or strategic assessment, without exposing sensitive core logic.
Shareable summary for an initial professional, technical or strategic assessment.
German version with the same structure for German-language review and internal circulation.
The brief classifies key statements by evidence status, limitation and next acceptance criterion. It allows a reviewer to see what is already documented and what Version 2 must still demonstrate before confidential material is needed.
Public review logic for Version 1, control groups, APS, reproduction and the Version 2 validation gates.
German version with the same evidence structure for German-language review.
The compact Fact Sheet condenses the architecture, documented research state, potential institutional relevance and staged review process into a single A4 page. It deliberately remains an initial institutional snapshot; the subsequently added planned live-validation layer is explained on the website and in the updated Executive Overview. For substantive review, the Executive Overview and Evidence & Validation Brief remain the more important documents.
Compact discussion and circulation document for an initial strategic fit check.
German one-page version for German-language strategic discussions.
Before a discussion, an interested party should have enough information to understand the core idea and the open validation work independently. Several public layers complement each other.
Core public statements with evidence status, limitation and next validation step.
02What is documented today, what is being re-tested and what is explicitly not yet claimed as complete.
03Test base, control group, metric definitions and Version 1 limitations – without unexplained headline numbers.
04How a published result should be traceable to the relevant data, rules, version and test conditions.
05Deeper explanations of hit ratio versus profit factor, intraday sequence and control groups.
06Technical terms are explained so that evaluation does not depend on knowing internal terminology.
07Historical APS publications with bibliographic detail and current classification.
08Potential relevance by institution type, transferable value layers and a fit check without a universal product promise.
09Staged path from public orientation through NDA and technical review to a potential transaction.
10Planned trading and research office, real-execution evidence chain, preferred acquisition objective and clearly separated alternative commercialisation paths.
For serious interest, information access should deepen with the review. This makes a discussion substantive without exposing source code, sensitive rules or proprietary implementation detail at first contact.
Website, Executive Overview, Evidence & Validation Brief, Evidence Map, project status, methodology, glossary and publication history. This layer answers whether the project is relevant enough for a discussion.
The discussion establishes whether the interest is primarily domain, technical, strategic or transaction-related. Only then is it useful to decide which material is actually needed.
A current confidential whitepaper exists for qualified discussions. Release is selective; sensitive material is not distributed merely because it exists.
As Version 2 progresses, replication and validation reports, data and test definitions, architecture documents and documented deviations are intended to become reviewable. Such material is labelled complete only after the relevant test has actually been completed.
Complete rule sets, proprietary implementation details, source code or similarly sensitive material belong at the end of a serious review and are disclosed only to the extent required by the specific purpose.
The document layer grows alongside revalidation. Existing material is separated from controlled material and from reports that can only be completed once the corresponding Version 2 validation work has been completed.
This layer is not intended as a public download area.
These documents are created with the relevant validation work; they are not presented as complete in advance.
If the website and Executive Overview lead to concrete questions, they can be sent directly by email. This allows the discussion to start at the relevant project state instead of with a blanket data-room release.